Democrats continue to declare that President Trump and his fellow Republicans want to deny healthcare to millions of Americans, especially those with pre-existing conditions. It’s not true.
Problems Continue with 340B Program
Berkeley Research Group report shows once again how 340B has been corrupted and is being abused.
President Trump’s New Executive Order: Deserves Praise and Raises Questions
President Trump has announced a new EO, the “America-First Healthcare Plan” and lists the great accomplishments achieved in healthcare reform, but also raises questions and concerns.
Pandemic Spending Demonstrates Disconnect in Pentagon’s Priorities
Pentagon officials used money provided for pandemic preparedness to support local jobs. This should mark the end of further stimulus funding for the Department of Defense.
Canada Just Says No to Drug Importation
The OMB is reviewing the final rule that would allow states to import drugs from Canada.
RSC American Worker Report Deserves Consideration in Congress
The Republican Study Committee American Worker Task Force report includes more than 100 recommendations on education, labor, and welfare programs that would eliminate wasteful spending and increase the efficiency of the federal government.
Most Favored Nation Policy: Unfavorable to U.S. Pharmaceutical Research
President Trump signs controversial Executive Order (EO) implementing “most favored nation” policy to lower drug costs.
Healthcare Transparency: May Not Work as Intended
President Trump’s health insurance transparency rule may not accomplish what is intended.
Now Is the Time for Occupational Licensing Reform
During the coronavirus pandemic, states have made changes in occupational licensing laws. However, it is important to discuss reform outside of the pandemic.
A Fool’s Errand to Lower Drug Costs?
On August 31, the California state legislature passed, SB 852, The California Affordable Drug Manufacturing Act of 2020, which would allow the state to partner with drug manufacturers to produce their own line of pharmaceuticals.